ADXN · Addex Therapeutics Ltd ADR
United States · RS rating 13 · As of 2026-11-03
| Price | 3.00 USD |
|---|---|
| 1-day change | +0.5% |
| RS rating (overall / 1M / 3M / 12M) | 13 / 49 / 10 / 14 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 26 / 6 / 45 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +50.0% |
| Sales growth Q/Q | -99.2% |
| Distance from 52-week high | +68.0% |
| Market cap (USD) | $7.6M |